SPARC — Sun Pharma Advanced Research Share News
0.000.00%
Last trade - 00:00- IN₹55.74bn
- IN₹61.31bn
- IN₹391.48m
Brief: Sun Pharma Advanced Research Says Two Serious Adverse Events In SCO-088
India's Sun Pharma rises; report says regulator clears co of fraud claims
Brief: India's Sun Pharma Advanced Research Company June-Qtr Loss Widens
Brief: Sun Pharma Advanced Research Gets Orphan Drug Designation From USFDA For SCO-088
Brief: Sun Pharma Advanced Research Says USFDA Accepted Co's NDA For Taclantis
Brief: Hitgen And Sparc Enter Dna-Encoded Library Based Innovative Drug Discovery Research Collaboration
Brief: Sun Pharma Advanced Research Enters Research Collaboration With Hitgen Ltd
Brief: Sun Pharma Advanced Research Says Sun Pharma Global FZE Plans To Not Launch Elepsiatm XR
Reuters Insider - Asia Insight: Stocks reach four-month peak on U.S.-China trade deal hopes
Brief: Sun Pharma Advanced Research Co Updates On Order From Office Of Commissioner Of GST & Central Excise
Brief: India's Sun Pharma Advanced Research Company Dec Qtr Loss Widens
Brief: Schrödinger, SPARC Announce Collaboration to Accelerate Neurodegeneration Drug Development Program
India's Sun Pharma Advanced Research gains after update on key drugs
Brief: India's Sun Pharma Advanced Research Co June-Qtr Loss Narrows
India's Sun Pharma hits over 3-mth high after U.S. FDA lifts supply curbs
India's Sun Pharma rises; U.S. FDA issues VAI status to Halol plant
Brief: India's Sun Pharma Advanced Research Co Posts March-Qtr Profit
Brief: Sun Pharma Advanced Research Gets Demand Notice For Assessment Yr 2014-15
Brief: India's Sun Pharma Advanced Research Co Dec Qtr Loss Narrows